SPRY · NASDAQ

ARS Pharmaceuticals, Inc.

Q: How do I get SPRY news from the API?

Call GET /v1/news?tickers=SPRY. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search articles since 2020 in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees articles since 2020.

$3.00 -0.33 (-9.91%)

Company overview

ARS Pharmaceuticals, Inc. develops ARS-1, a novel intranasal epinephrine spray with absorption technology for patients and their families at risk of severe allergic reactions to food, medications, and insect bites. Its product includes Neffy, a low-dose intranasal epinephrine nasal spray. The company was incorporated in 2015 and is based in San Diego, California.

Sector: Healthcare
Industry: Biotechnology
Exchange: NASDAQ
Market cap: $298M
Employees: 155
Headquarters: San Diego, CA
Website: ars-pharma.com
CEO: Richard E. Lowenthal
Listed: December 4, 2020
P/E: -1.49
Dividend yield: 0.00%

Company financials

Revenue: $99M
Gross profit: $76.3M
Operating income: -$202M
EBITDA: -$194M
Net income: -$198M
EPS: -$2.01
Total assets: $288M
Total debt: $97.1M
Gross margin: 77.10%
Net margin: -200.00%
Earnings yield: -67.00%

Revenue segmentation

By product (FY 2025)

By region (FY 2025)

Showing FY 2025

Price chart

SPRY 1D NASDAQ O3.40H3.49L2.91C3.05-0.33 (-9.91%)Vol1.57M

News

Ticker	Type	Headline	Source	Published
SPRYARS Pharmaceuticals, Inc.	Stock news	ARS Pharmaceuticals: Lawsuits And Cash Burn Are Priced In, Yet The Stock Keeps Falling	Seeking Alpha	Nov 3, 1:19:31 AM ET
SPRYARS Pharmaceuticals, Inc.	Stock news	ARS Pharmaceuticals, Inc. (SPRY) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release	Zacks Investment Research	Oct 29, 11:02:02 AM ET
SPRYARS Pharmaceuticals, Inc.	Press release	ARS Pharma to Report Third Quarter 2026 Financial Results	GlobeNewswire	Oct 28, 4:01:00 PM ET
SPRYARS Pharmaceuticals, Inc.	Press release	Lifshitz Law PLLC Announces Investigations of Replimune Group, Inc. (NASDAQ: REPL), Datavault AI Inc. (NASDAQ: DVLT), Blaize Holdings, Inc. (NASDAQ: BZAI), and ARS Pharmaceuticals (NASDAQ: SPRY)	ACCESS Newswire	Oct 27, 12:17:00 PM ET
SPRYARS Pharmaceuticals, Inc.	Legal	SPRY FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds ARS Pharmaceuticals Investors of Securities Class Action Lawsuit Deadline on October 5, 2026	Business Wire	Oct 5, 8:45:00 AM ET
SPRYARS Pharmaceuticals, Inc.	Legal	SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law	GuruFocus	Oct 5, 4:00:00 AM ET
SPRYARS Pharmaceuticals, Inc.	Legal	ARS Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SPRY	GuruFocus	Oct 5, 4:00:00 AM ET
SPRYARS Pharmaceuticals, Inc.	Legal	ARS PHARMACEUTICALS DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important October 5 Deadline in Securities Class Action - SPRY	Newsfile Corp	Oct 4, 2:16:00 PM ET
SPRYARS Pharmaceuticals, Inc.	Legal	ARS PHARMACEUTICALS DEADLINE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages ARS Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important October 5 Deadline in Securities Class Action - SPRY	Newsfile Corp	Oct 3, 7:24:00 AM ET
SPRYARS Pharmaceuticals, Inc.	Legal	ARS Pharmaceuticals Deadline: SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit	PR Newswire	Oct 2, 6:01:00 PM ET
SPRYARS Pharmaceuticals, Inc.	Legal	ARS PHARMACEUTICALS DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important October 5 Deadline in Securities Class Action – SPRY	GlobeNewswire	Oct 2, 2:57:00 PM ET
SPRYARS Pharmaceuticals, Inc.	Legal	ARS PHARMACEUTICALS DEADLINE MONDAY: Bragar Eagel & Squire, P.C. Reminds ARS Pharmaceuticals Investors to Contact the Firm Before October 5th Seeking Lead Plaintiff Role	GlobeNewswire	Oct 2, 2:43:00 PM ET
SPRYARS Pharmaceuticals, Inc.	Legal	Kaplan Fox Class Action Reminder: ARS Pharmaceuticals Inc. (SPRY) Lead Plaintiff Deadline is October 5, 2026	Newsfile Corp	Oct 1, 4:30:00 PM ET
SPRYARS Pharmaceuticals, Inc.	Legal	SPRY SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds ARS Pharmaceuticals Investors of Securities Class Action Lawsuit Deadline on October 5, 2026	PRNewsWire	Oct 1, 9:53:00 AM ET
SPRYARS Pharmaceuticals, Inc.	Legal	ARS PHARMACEUTICALS DEADLINE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages ARS Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important October 5 Deadline in Securities Class Action - SPRY	Newsfile Corp	Sep 30, 3:51:00 PM ET
SPRYARS Pharmaceuticals, Inc.	Legal	Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 5, 2026 in ARS Pharmaceuticals Inc. Lawsuit - SPRY	PR Newswire	Sep 30, 12:51:00 PM ET
SPRYARS Pharmaceuticals, Inc.	Legal	Kaplan Fox Notifies Investors: Deadline to Lead in the ARS Pharmaceuticals Inc. (SPRY) Securities Class Action is October 5, 2026	Newsfile Corp	Sep 29, 6:55:00 PM ET
SPRYARS Pharmaceuticals, Inc.	Legal	SueWallSt Reminds ARS Pharmaceuticals Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of October 5, 2026 - SPRY	GlobeNewswire	Sep 29, 10:12:00 AM ET
SPRYARS Pharmaceuticals, Inc.	Legal	Portnoy Law Firm Announces Class Action on Behalf of ARS	GlobeNewswire	Sep 29, 9:00:00 AM ET
SPRYARS Pharmaceuticals, Inc.	Legal	ARS PHARMACEUTICALS DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important October 5 Deadline in Securities Class Action - SPRY	Newsfile Corp	Sep 29, 7:45:00 AM ET

FAQ

Questions about ARS Pharmaceuticals, Inc.

What does ARS Pharmaceuticals, Inc. do?

What is SPRY's market cap?

ARS Pharmaceuticals, Inc. (SPRY) is a listed stock with a live quote. The latest market cap on this page is $298M.

Where is ARS Pharmaceuticals, Inc. headquartered?

ARS Pharmaceuticals, Inc. is headquartered in San Diego, CA.

How do I get SPRY news from the API?

Call GET /v1/news?tickers=SPRY. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search articles since 2020 in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees articles since 2020.

How far back does SPRY news go?

Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for SPRY, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees articles since 2020 as headlines are ingested. A Free API key returns the last year. Pro keys search articles since 2020.

Is the SPRY price on this page from the API?

The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.

Can I use the Pro plan commercially?

No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 1,000 REST requests a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.

Start 7-day free trial Read the docs